Core Viewpoint - Chengzhi Holdings (01741.HK) reported an increase in revenue for the fiscal year ending September 30, 2025, with a rise of approximately 5.8% from about HKD 144 million to approximately HKD 152 million [1] Financial Performance - Revenue from continuing operations increased from approximately HKD 144 million for the year ending September 30, 2024, to approximately HKD 152 million for the year ending September 30, 2025 [1] - The annual loss for the year ending September 30, 2024, was approximately HKD 10.1 million, which increased to a loss of approximately HKD 12 million for the year ending September 30, 2025 [1] - Basic and diluted loss per share for continuing and discontinued operations were approximately HKD 0.015 and HKD 0.0126, respectively, for the years ending September 30, 2025, and September 30, 2024 [1]

Financial Performance - Revenue from continuing operations increased by approximately 5.8% from HK$144.0 million for the year ended September 30, 2024, to HK$152.4 million for the year ended September 30, 2025[3]. - Gross profit rose by approximately 18.2% from HK$9.9 million for the year ended September 30, 2024, to HK$11.7 million for the year ended September 30, 2025[3]. - Gross margin improved from approximately 6.9% for the year ended September 30, 2024, to approximately 7.7% for the year ended September 30, 2025[3]. - The annual loss for the year ended September 30, 2025, was approximately HK$12.0 million, compared to a loss of approximately HK$10.1 million for the year ended September 30, 2024[3]. - Basic and diluted loss per share for continuing and discontinued operations was approximately HK$1.50 for the year ended September 30, 2025, compared to HK$1.26 for the year ended September 30, 2024[6]. - The group reported a pre-tax loss of HKD 11,972,000 for the fiscal year ending September 30, 2025, compared to a pre-tax loss of HKD 10,016,000 in the previous year[19]. - The group recorded a net profit of approximately HKD 13.3 million from discontinued operations for the year ending September 30, 2024, primarily due to the sale of a subsidiary engaged in health management[43]. - Net loss increased by approximately HKD 1.9 million to about HKD 12.0 million for the year ending September 30, 2025, compared to a net loss of about HKD 10.1 million for the year ending September 30, 2024[44]. Assets and Liabilities - Total assets decreased from HK$64.1 million as of September 30, 2024, to HK$49.2 million as of September 30, 2025[7]. - Total liabilities decreased from HK$29.4 million as of September 30, 2024, to HK$26.5 million as of September 30, 2025[8]. - Cash and cash equivalents decreased from HK$32.6 million as of September 30, 2024, to HK$22.4 million as of September 30, 2025[7]. - Trade receivables decreased from HKD 16,841,000 in 2024 to HKD 10,580,000 in 2025, reflecting a reduction in outstanding amounts[30]. - Trade payables decreased from HKD 12,595,000 in 2024 to HKD 6,715,000 in 2025, indicating improved cash flow management[32]. - The group's net current assets were approximately HKD 23.4 million as of September 30, 2025, down from about HKD 34.9 million as of September 30, 2024[49]. - The capital debt ratio increased to approximately 15.6% as of September 30, 2025, compared to about 8.5% as of September 30, 2024[50]. Revenue Breakdown - The revenue breakdown includes HKD 38,477,000 from foundation and site preparation works, HKD 45,493,000 from general construction and related services, and HKD 60,790,000 from other construction works[18]. - The construction segment of foundation and site formation engineering contributed HKD 38.5 million or 25.2% to total revenue, while general construction and related services contributed HKD 45.5 million or 29.9%[38]. - The group's revenue for the fiscal year ending September 30, 2025, was HKD 152,394,000, an increase from HKD 143,956,000 in the previous year, representing a growth of approximately 5.3%[14]. - The group's revenue increased by approximately HKD 8.4 million or 5.8% to about HKD 152.4 million for the year ending September 30, 2025, compared to HKD 144.0 million for the previous year[38]. - The group's revenue from Hong Kong for the fiscal year ending September 30, 2025, was HKD 152,394,000, while revenue from discontinued operations in China was HKD 17,053,000 in the previous year[20]. Operational Focus - The company continues to engage in foundation and site formation works, general building works, and related services, indicating ongoing operational focus[9]. - The group has 20 ongoing construction projects, with significant projects including slope works in North Fanling and site formation works in Tseung Kwan O, expected to complete between 2025 and 2026[35][36]. - The company has ceased its health management business in China following the sale of its subsidiary for HKD 50,000, focusing solely on construction projects in Hong Kong[36]. Cost Management - The group’s administrative and other operating expenses for the fiscal year ending September 30, 2025, were HKD 26,377,000, compared to HKD 73,291,000 in the previous year[18]. - Administrative and other operating expenses decreased by approximately HKD 6.9 million or 20.7% to about HKD 26.4 million for the year ending September 30, 2025[42]. - The group’s financial performance was affected by depreciation expenses, including HKD 281,000 for right-of-use assets and HKD 18,843,000 for employee benefits, including director remuneration[21]. - Total employee costs for the year ending September 30, 2025, were approximately HKD 18.8 million, down from about HKD 43.8 million for the year ending September 30, 2024[56]. Future Plans and Investments - The company has upgraded its accounting system to enhance document preparation, while the upgrade of the human resources management system is still in progress due to the lack of suitable options identified[60]. - The company has purchased a drilling rig, a rock drilling machine, two small piling machines, and four air compressors as part of its operational expansion[57]. - The company has increased the capital of two subsidiaries, Po Cheng Construction Co., Ltd. and Wong On Construction Co., Ltd., to support operational funding requirements[57]. - The company has recruited additional personnel, including two project managers, two project engineers, and other specialists to enhance its human resources[57]. - The company has allocated HKD 21.8 million for the initial costs of three construction projects, which have been fully utilized[64]. - The company plans to utilize the remaining net proceeds by September 30, 2026, in accordance with the IPO prospectus and the announcement of the use of proceeds[65]. - The company has upgraded its engineering and design systems to facilitate project planning, design, and management through automation[61]. - The company has maintained a prudent cash management policy to ensure a strong liquidity position for future growth opportunities[66]. Audit and Compliance - The Audit Committee held two meetings during the year ending September 30, 2025, to review the annual and interim financial performance and internal control systems[73]. - The independent auditor confirmed that the consolidated financial statements for the year ending September 30, 2025, comply with applicable accounting standards and listing rules[74]. - The independent auditor issued a qualified opinion due to insufficient audit evidence regarding the financial performance and cash flows of the disposed subsidiary, Daywin Group, for the period leading up to its sale[75]. - The management believes that the qualified opinion will not have a continuing impact on the consolidated financial statements due to the sale of Daywin Group[79]. - The Audit Committee agrees with the management's view that the qualified opinion will not affect the ongoing financial statements of the company[80]. Shareholder Relations - The company expresses gratitude to shareholders, customers, suppliers, and subcontractors for their continued support[81].

Core Viewpoint - Chengzhi Holdings (01741.HK) announced a board meeting scheduled for December 30, 2025, to consider and approve the company's performance for the year ending September 30, 2025, along with the potential declaration of a final dividend, if any [1] Group 1 - The board meeting will focus on the performance results of the company and its subsidiaries for the fiscal year [1] - The meeting will also consider the distribution of a final dividend, subject to approval [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 SHING CHI HOLDINGS LIMITED 成志控股有限公司 （於開曼群島註冊成立之有限公司） 成志控股有限公司（「本公司」）之董事（「董事」）會（「董事會」）謹此宣佈於2025年12月30日（星期二）舉行 董事會會議，藉以考慮及通過（其中包括）本公司連同其附屬公司截至2025年9月30日止年度業績及其 發佈，以及考慮派發末期股息（如有）。 承董事會命 成志控股有限公司 主席兼執行董事 劉志宏 香港，2025年12月15日 於本公告日期，董事會成員包括執行董事劉志宏博士、劉志明先生、劉志強博士及劉恩琪女士；及 獨立非執行董事為梁秉綱先生、彭嘉恆先生及黃鎮南先生。 （股份代號：1741） 董事會會議通告 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 成志控股有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | FF301 II. 已發行股份及/或庫存股份變動 | 1. ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 成志控股有限公司 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 本月底法定/註冊股本總額： HKD 20,000,000 F ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | 狀態: | 新提交 | | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | 公司名稱: | 成志控股有限公司 | | | | 呈交日期: | 2025年10月2日 | | | | I. 法定/註冊股本變動 | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 2,0 ...

本程序以英文製作，如若中英文版本出現差異或不一致，應以英文版本為準。 SHING CHI HOLDINGS LIMITED 成志控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1741） （「本公司」） 提名委員會 職權範圍 提名委員會（「本委員會」）的職權範圍是根據香港聯合交易所有限公司證券上市規則（分別為「聯交所」 及「上市規則」）相關要求制訂。 組成 權限 職責 2 6. 每年舉行的會議須至少一次。如本委員會的工作需要時，應該舉行額外會議。 7. 會議的法定人數為本委員會兩名成員。 8. 本委員會成員可以親身出席、電話或視像會議之形式參與會議。 9. 本委員會的決議案應當由本委員會成員的過半數通過。 10. 所有本委員會成員共同簽署之書面決議案與正式召開之委員會會議上通過之決議案同樣有效。 11. 除本文另有規定外，本委員會的會議程序受組織章程細則的相關條文（不時予以修訂）規限。 1. 本委員會乃本公司董事會（「董事」或「董事會」）根據本公司組織章程細則（「組織章程細則」）規定， 於本公司股份於聯交所上市之日起正式成立。 成員 秘書 5. 本委員會的秘書由本公司的公司秘書或由本委員會委任任何 ...

第 1 頁 共 10 頁 v 1.1.1 | 截至月份: | 2025年8月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 成志控股有限公司 | | | | | | 呈交日期: | 2025年9月1日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | ...

致：香港交易及結算所有限公司 公司名稱: 成志控股有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 2025年7月31日 狀態: 新提交 | | --- | | 截至月份 ...